Overview
The Effect of Darbepoetin Upon Rehabilitation for Colorectal Cancer Surgery
Status:
Completed
Completed
Trial end date:
2006-01-01
2006-01-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The study is investigating whether randomization to perioperative darbepoetin alfa treatment improves the rehabilitation following surgery for colonic and rectal cancer.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Herning HospitalCollaborator:
AmgenTreatments:
Darbepoetin alfa
Criteria
Inclusion Criteria:- Planned colonic and rectal surgery because of presumed cancer disease in the colon and
rectum
Exclusion Criteria:
- Psychiatric disease or dementia
- Diseases, that renders participation in the study impossible
- Thromboembolic disease within the last three months
- Dysregulated hypertension (systolic blood pressure>175 mmHg and/or diastolic blood
pressure>105 mmHg)
- Other diseases or causes that will contraindicate treatment with Darbepoetin Alfa
- Other diseases or causes that will contraindicate further treatment with Darbepoetin
Alfa
- Patients that preoperatively and/or four days postoperatively have a hemoglobin
concentration > 14 g/dl
- Former cancer disease
- Disseminated cancer disease
- Rectal cancer stage T4